Closure Medical (NASDAQ:CLSR)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Closure Medical Charts. Click Here for more Closure Medical Charts.](/p.php?pid=staticchart&s=N%5ECLSR&p=8&t=15)
CLOSURE Medical Corporation Stockholders to Vote on Johnson &
Johnson Merger
Stockholders of Record on April 22, 2005 Eligible to Vote
RALEIGH, N.C., April 28 /PRNewswire-FirstCall/ -- CLOSURE Medical Corporation
(NASDAQ:CLSR) today announced that its stockholders will vote on Thursday, June
2, 2005, on a proposal to approve the merger agreement between Johnson &
Johnson, Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson &
Johnson and CLOSURE Medical Corporation.
Stockholders of record as of April 22, 2005, will be entitled to vote and will
be mailed a definitive proxy statement in connection with the meeting.
On March 4, 2005, CLOSURE announced that it had entered into a definitive
agreement whereby Johnson & Johnson or its direct or indirect wholly owned
subsidiaries would acquire CLOSURE.
About CLOSURE Medical Corporation
CLOSURE Medical Corporation is a global leader in the development and
manufacture of innovative biomaterial-based medical devices that fulfill the
needs of healthcare practitioners, patients and consumers.
For additional information on CLOSURE Medical visit its website at
http://www.closuremed.com/ or visit the "Clients" section of the Allen & Caron
website at http://www.allencaron.com/.
This release includes forward-looking statements that are based on assumptions
about many important factors, including the approval by CLOSURE stockholders of
the acquisition; regulatory approvals of the transaction; general industry and
market conditions; general domestic and international economic conditions, such
as interest rate and currency exchange rate fluctuations; technological
advances and patents attained by competitors; challenges inherent in new
product development, including obtaining regulatory approvals and the factors
listed in CLOSURE's most recent 10-K. As such, they involve risks that could
cause actual results to differ materially. The Company does not undertake to
update its forward-looking statements.
This material is not a substitute for the proxy statement CLOSURE Medical will
file with the Securities and Exchange Commission. Investors are urged to read
the proxy statement, including detailed risk factors, when it becomes
available, because it will contain important information. The proxy statement
and other documents, which will be filed by CLOSURE Medical with the Securities
and Exchange Commission, will be available free of charge at the SEC's website,
http://www.sec.gov/, or by visiting CLOSURE Medical's website at
http://www.closuremed.com/ or the "Clients" section of the Allen & Caron
website at http://www.allencaron.com/.
CLOSURE Medical and certain of its directors, executive officers and certain
other members of its management may be deemed to be soliciting proxies from
CLOSURE Medical's shareholders in connection with the proposed transaction.
Investors may obtain a detailed list of names, affiliations and interests of
CLOSURE Medical participants in the solicitation of proxies of CLOSURE
Medical's shareholders by reading the proxy statement when it becomes
available.
DATASOURCE: CLOSURE Medical Corporation
CONTACT: Investors, Joe Allen, +1-212-691-8087, , or
Media, Len Hall, +1-949-474-4300, , both for CLOSURE Medical
Corp; or Benny Ward, CFO of CLOSURE Medical Corp, +1-919-876-7800
Web site: http://www.closuremed.com/
http://www.allencaron.com/